OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment-Reference-Cited by-同舟云学术

OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment

Published:2022-04-29 Issue:22 Volume:41 Page:3131-3150
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chen Ziyang^ORCID,Zhang Xiaogang^ORCID,Xing Zhe^ORCID,Lv Shuaijun^ORCID,Huang Linxuan^ORCID,Liu Jingping^ORCID,Ye Shubiao^ORCID,Li Xinyao^ORCID,Chen Meiqi^ORCID,Zuo Shaowen^ORCID,Tao Yingxu^ORCID,He Yumei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02324-8.pdf

Reference75 articles.

1. Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018;16:359–69.

2. Messersmith WA. NCCN guidelines updates: management of metastatic colorectal cancer. J Natl Compr Canc Netw. 2019;17:599–601.

3. Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019;68:1820–6.

4. Liao W, Overman MJ, Boutin AT, Shang X, Zhao D, Dey P, et al. KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer. Cancer Cell. 2019;35:559–72 e7.

5. Kajino-Sakamoto R, Fujishita T, Taketo MM, Aoki M. Synthetic lethality between MyD88 loss and mutations in Wnt/beta-catenin pathway in intestinal tumor epithelial cells. Oncogene 2021;40:408–20.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OLFM4 modulates intestinal inflammation by promoting IL-22+ILC3 in the gut;Communications Biology;2024-07-29

2. Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy;MedComm;2024-06-22

3. Heterogeneity of myeloid cells in common cancers: Single cell insights and targeting strategies;International Immunopharmacology;2024-06

4. Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies;Journal of Cancer Research and Clinical Oncology;2024-05-08

5. Blocking OLFM4/galectin-3 axis in placental polymorphonuclear myeloid-derived suppressor cells triggers intestinal inflammation in newborns;International Immunopharmacology;2024-05